These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11309232)

  • 1. Depressor and regionally-selective vasodilator effects of human and rat urotensin II in conscious rats.
    Gardiner SM; March JE; Kemp PA; Davenport AP; Bennett T
    Br J Pharmacol; 2001 Apr; 132(8):1625-9. PubMed ID: 11309232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional heterogeneity in the haemodynamic responses to urotensin II infusion in relation to UT receptor localisation.
    Gardiner SM; March JE; Kemp PA; Maguire JJ; Kuc RE; Davenport AP; Bennett T
    Br J Pharmacol; 2006 Mar; 147(6):612-21. PubMed ID: 16314853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human urotensin-II is an endothelium-dependent vasodilator in rat small arteries.
    Bottrill FE; Douglas SA; Hiley CR; White R
    Br J Pharmacol; 2000 Aug; 130(8):1865-70. PubMed ID: 10952676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bolus injection of human UII in conscious rats evokes a biphasic haemodynamic response.
    Gardiner SM; March JE; Kemp PA; Bennett T
    Br J Pharmacol; 2004 Oct; 143(3):422-30. PubMed ID: 15339862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential antagonism of alpha-1 and alpha-2 adrenoceptor-mediated vasoconstrictor responses by a vasodilator peptide, urotensin I: comparison with nifedipine.
    Bolt GR; Itoh H; Lederis K; MacCannell KL
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1147-54. PubMed ID: 2574741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urotensin II stimulates high frequency-induced ANP secretion via PLC-PI 3K-PKC pathway.
    Gao S; Shah A; Oh YB; Park WH; Kim SH
    Peptides; 2010 Jan; 31(1):164-9. PubMed ID: 19896516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of human urotensin-II infusion on hemodynamics and cardiac function.
    Hassan GS; Chouiali F; Saito T; Hu F; Douglas SA; Ao Z; Willette RN; Ohlstein EH; Giaid A
    Can J Physiol Pharmacol; 2003 Feb; 81(2):125-8. PubMed ID: 12710525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the dual metallopeptidase inhibitor, MDL 100,240, on regional haemodynamic responses to vasoactive peptides in conscious rats.
    Gardiner SM; Kemp PA; Brunner-Ferber F; Bennett T
    Br J Pharmacol; 1997 Dec; 122(8):1687-93. PubMed ID: 9422815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms involved in the regional haemodynamic effects of intermedin (adrenomedullin 2) compared with adrenomedullin in conscious rats.
    Jolly L; March JE; Kemp PA; Bennett T; Gardiner SM
    Br J Pharmacol; 2009 Aug; 157(8):1502-13. PubMed ID: 19681873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urotensin II evokes potent vasoconstriction in humans in vivo.
    Böhm F; Pernow J
    Br J Pharmacol; 2002 Jan; 135(1):25-7. PubMed ID: 11786476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of endotoxaemia on pressor and vasoconstrictor actions of angiotensin II and arginine vasopressin in conscious rats.
    Tarpey SB; Bennett T; Randall MD; Gardiner SM
    Br J Pharmacol; 1998 Apr; 123(7):1367-74. PubMed ID: 9579732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal effects of human urotensin-II in rats with experimental congestive heart failure.
    Ovcharenko E; Abassi Z; Rubinstein I; Kaballa A; Hoffman A; Winaver J
    Nephrol Dial Transplant; 2006 May; 21(5):1205-11. PubMed ID: 16396970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of antibodies to TNF-alpha and IL-1beta on haemodynamic responses to the cytokines, and to lipopolysaccharide, in conscious rats.
    Gardiner SM; Kemp PA; March JE; Woolley J; Bennett T
    Br J Pharmacol; 1998 Dec; 125(7):1543-50. PubMed ID: 9884083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of prostaglandins in urotensin II-induced vasodilatation in the coronary arteries of aged rats.
    Ishihata A; Ogaki T; Aita T; Katano Y
    Eur J Pharmacol; 2005 Oct; 523(1-3):119-26. PubMed ID: 16226251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of calcitonin gene-related peptide receptor antagonism on the systemic blood pressure responses to mechanistically diverse vasomodulators in conscious rats.
    Lynch JJ; Detwiler TJ; Kane SA; Regan CP
    J Cardiovasc Pharmacol; 2010 Nov; 56(5):518-25. PubMed ID: 20729756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of indomethacin on the regional haemodynamic responses to low doses of endothelins and sarafotoxin.
    Gardiner SM; Compton AM; Bennett T
    Br J Pharmacol; 1990 May; 100(1):158-62. PubMed ID: 2196965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urotensin-II induces ear flushing in rats.
    Qi JS; Schulingkamp R; Parry TJ; Colburn R; Stone D; Haertlein B; Minor LK; Andrade-Gordon P; Damiano BP
    Br J Pharmacol; 2007 Feb; 150(4):415-23. PubMed ID: 17211454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenteric vasoconstriction and hindquarters vasodilatation accompany the pressor actions of exendin-4 in conscious rats.
    Gardiner SM; March JE; Kemp PA; Bennett T
    J Pharmacol Exp Ther; 2006 Feb; 316(2):852-9. PubMed ID: 16221740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urotensin II is a nitric oxide-dependent vasodilator and natriuretic peptide in the rat kidney.
    Zhang AY; Chen YF; Zhang DX; Yi FX; Qi J; Andrade-Gordon P; de Garavilla L; Li PL; Zou AP
    Am J Physiol Renal Physiol; 2003 Oct; 285(4):F792-8. PubMed ID: 12783779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the novel selective endothelin ET(A) receptor antagonist, SB 234551, on the cardiovascular responses to endotoxaemia in conscious rats.
    Gardiner SM; March JE; Kemp PA; Bennett T
    Br J Pharmacol; 2001 Aug; 133(8):1371-7. PubMed ID: 11498524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.